🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, randomized, multicenter Phase 2 study to assess the ...
Status
Recruiting
Location
Central Alabama Research
Start Date
2026-04-30
Trial ID
NCT07446322
Treatments Being Tested
The purpose of this study is to find out if giving reolysin in combination ...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2012-10-26
Trial ID
NCT01622543
Treatments Being Tested
The purpose of this Phase 2 study is to investigate whether intravenous adm...
Status
Completed
Location
Montefiore Medical Center
Start Date
2009-10
Trial ID
NCT00998322
Treatments Being Tested
The purpose of this Phase 2 study is to investigate whether intravenous adm...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2009-10
Trial ID
NCT00998192
Treatments Being Tested
This phase I/II trial studies the safety of the combination of bortezomib, ...
Status
Active Not Recruiting
Location
Los Angeles County-USC Medical Center
Start Date
2022-10-07
Trial ID
NCT05514990
Treatments Being Tested
This pilot phase I trial studies the side effects and the best dose of givi...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2012-04
Trial ID
NCT01533194
Treatments Being Tested
This phase I trial studies the side effects and best dose of wild-type reov...
Status
Completed
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2018-10-24
Trial ID
NCT03605719
Treatments Being Tested
The purpose of this Phase 2 study is to investigate whether intravenous adm...
Status
Completed
Location
Cancer Therapy & Research Center at UTHSCSA
Start Date
2009-09
Trial ID
NCT00984464
Treatments Being Tested
This is a phase 2 study to evaluate the safety and efficacy of the combinat...
Status
Active Not Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2020-07-13
Trial ID
NCT04445844
Treatments Being Tested
The purpose of this study is to find out if pelareorep in combination with ...
Status
Terminated
Location
ICO Badalona
Start Date
2019-03-29
Trial ID
NCT04102618
Treatments Being Tested